JP2006508116A - Ｌｔｄ４アンタゴニストとしての新規三環式誘導体 - Google Patents

Ｌｔｄ４アンタゴニストとしての新規三環式誘導体 Download PDF

Info

Publication number
JP2006508116A
JP2006508116A JP2004550982A JP2004550982A JP2006508116A JP 2006508116 A JP2006508116 A JP 2006508116A JP 2004550982 A JP2004550982 A JP 2004550982A JP 2004550982 A JP2004550982 A JP 2004550982A JP 2006508116 A JP2006508116 A JP 2006508116A
Authority
JP
Japan
Prior art keywords
dihydro
pyridin
benzoxepino
thio
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004550982A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508116A5 (enExample
Inventor
カルロス・プイグ・ドゥラン
ダニエル・ペレス・クレスポ
ジョルディ・バッチ・タナ
ハミシュ・ライダー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall Prodesfarma Sosiedad Anonima
Original Assignee
Almirall Prodesfarma Sosiedad Anonima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32309630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2006508116(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Prodesfarma Sosiedad Anonima filed Critical Almirall Prodesfarma Sosiedad Anonima
Publication of JP2006508116A publication Critical patent/JP2006508116A/ja
Publication of JP2006508116A5 publication Critical patent/JP2006508116A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Paints Or Removers (AREA)
JP2004550982A 2002-11-12 2003-11-11 Ｌｔｄ４アンタゴニストとしての新規三環式誘導体 Pending JP2006508116A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200202590A ES2211315B1 (es) 2002-11-12 2002-11-12 Nuevos compuestos triciclicos.
PCT/EP2003/012581 WO2004043966A1 (en) 2002-11-12 2003-11-11 New tricyclic derivatives as ltd4 antagonists

Publications (2)

Publication Number Publication Date
JP2006508116A true JP2006508116A (ja) 2006-03-09
JP2006508116A5 JP2006508116A5 (enExample) 2006-11-24

Family

ID=32309630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004550982A Pending JP2006508116A (ja) 2002-11-12 2003-11-11 Ｌｔｄ４アンタゴニストとしての新規三環式誘導体

Country Status (19)

Country Link
US (1) US7557212B2 (enExample)
EP (1) EP1560834B1 (enExample)
JP (1) JP2006508116A (enExample)
KR (1) KR20050074605A (enExample)
CN (1) CN100379742C (enExample)
AT (1) ATE399170T1 (enExample)
AU (1) AU2003288032A1 (enExample)
BR (1) BR0315462A (enExample)
CA (1) CA2505491A1 (enExample)
CO (1) CO5700775A2 (enExample)
DE (1) DE60321810D1 (enExample)
EC (1) ECSP055844A (enExample)
ES (2) ES2211315B1 (enExample)
MX (1) MXPA05005017A (enExample)
NO (1) NO20052858L (enExample)
RU (1) RU2330855C2 (enExample)
UA (1) UA80996C2 (enExample)
WO (1) WO2004043966A1 (enExample)
ZA (1) ZA200503806B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159618A1 (ja) * 2016-03-18 2017-09-21 石原産業株式会社 有害生物防除剤

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2257152B1 (es) 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
AU2005247105B2 (en) 2004-05-31 2010-11-11 Laboratorios Almirall, S.A. Combinations comprising antimuscarinic agents and corticosteroids
DK1896421T3 (da) 2005-06-23 2012-01-09 Merck Sharp & Dohme Benzocyclohetapyridiner som hæmmere af receptoren tyrosinkinase MET
CA2624656A1 (en) * 2005-10-21 2007-05-03 Merck & Co., Inc. Tyrosine kinase inhibitors
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2108641A1 (en) 2008-04-11 2009-10-14 Laboratorios Almirall, S.A. New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2113503A1 (en) 2008-04-28 2009-11-04 Laboratorios Almirall, S.A. New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
EP2322176A1 (en) 2009-11-11 2011-05-18 Almirall, S.A. New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
CA2842881A1 (en) 2011-07-26 2013-04-11 Rajendrasinh RATHOD Cysteinyl leukotriene antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03163075A (ja) * 1989-08-22 1991-07-15 Merck Frosst Canada Inc ロイコトリエン類の生合成阻害剤としての（キノリン―２―イルメトキシ）インドール類
WO1994019345A1 (fr) * 1993-02-16 1994-09-01 Ube Industries, Ltd. Derive de quinoleine
WO2001047889A1 (en) * 1999-12-28 2001-07-05 Ube Industries, Ltd. Tricyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341044C (en) * 1988-04-28 2000-07-04 Frank J. Villani Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use
ATE266025T1 (de) * 1997-11-25 2004-05-15 Schering Corp Thrombin-rezeptor antagonisten
JP2006151809A (ja) * 2002-12-26 2006-06-15 Ube Ind Ltd ベンゾシクロヘプタピリジン化合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03163075A (ja) * 1989-08-22 1991-07-15 Merck Frosst Canada Inc ロイコトリエン類の生合成阻害剤としての（キノリン―２―イルメトキシ）インドール類
WO1994019345A1 (fr) * 1993-02-16 1994-09-01 Ube Industries, Ltd. Derive de quinoleine
WO2001047889A1 (en) * 1999-12-28 2001-07-05 Ube Industries, Ltd. Tricyclic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017159618A1 (ja) * 2016-03-18 2017-09-21 石原産業株式会社 有害生物防除剤

Also Published As

Publication number Publication date
CN100379742C (zh) 2008-04-09
CN1735618A (zh) 2006-02-15
CA2505491A1 (en) 2004-05-27
US7557212B2 (en) 2009-07-07
ECSP055844A (es) 2005-09-20
US20060116363A1 (en) 2006-06-01
RU2005118757A (ru) 2006-02-27
CO5700775A2 (es) 2006-11-30
EP1560834A1 (en) 2005-08-10
ZA200503806B (en) 2006-08-30
ES2211315A1 (es) 2004-07-01
NO20052858D0 (no) 2005-06-13
MXPA05005017A (es) 2005-08-03
ATE399170T1 (de) 2008-07-15
AU2003288032A1 (en) 2004-06-03
ES2211315B1 (es) 2005-10-16
KR20050074605A (ko) 2005-07-18
EP1560834B1 (en) 2008-06-25
WO2004043966A1 (en) 2004-05-27
ES2306906T3 (es) 2008-11-16
DE60321810D1 (de) 2008-08-07
RU2330855C2 (ru) 2008-08-10
BR0315462A (pt) 2005-08-23
UA80996C2 (en) 2007-11-26
NO20052858L (no) 2005-08-12

Similar Documents

Publication Publication Date Title
JP4054368B2 (ja) 置換メチルアリール又はヘテロアリールアミド化合物
EP1560834B1 (en) New tricyclic derivatives as ltd4 antagonists
AU721139B2 (en) Pyridazino quinoline compounds
US5236937A (en) Pyridinyl compounds which are useful as angiotensin ii antagonists
WO2014183555A1 (zh) 环烷基甲酸类衍生物、其制备方法及其在医药上的应用
WO1999037622A1 (en) Nitrogenous heterocyclic derivatives and medicine thereof
SK932003A3 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
CN105814053B (zh) 作为tnf活性调节剂的咪唑并吡啶衍生物
WO2007032466A1 (ja) 複素環化合物、その製造方法並びに用途
JP2008533198A (ja) イミダゾ［１，２−ａ］ピリジン誘導体：製造および医薬用途
JP7148650B2 (ja) 化合物、組成物及びその薬物製造における用途
CN103097355A (zh) 用于治疗皮肤病的新的喹啉酯
AU2020256301A1 (en) Fused bicyclic compounds for the treatment of disease
KR20230104151A (ko) 아세트아미도-페닐테트라졸 유도체 및 그의 사용 방법
JPH0788361B2 (ja) ロイコトリエン拮抗剤としてのキノリン含有ケト酸
SK83896A3 (en) Diaryl-5,6-condensed heterocyclic acids, pharmaceutical agent containing them and their use
CZ20033519A3 (en) Dibenzocycloheptene compound
HU222274B1 (hu) Leukotrién antagonista hatású diaril-5,6-(kondenzált heterociklusos savak), eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
JPH09504777A (ja) ロイコトリエンアンタゴニストとしてのキノリン誘導体
WO2001014384A1 (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
CN105820165B (zh) α-咔啉类化合物，其制备方法以及用途
JPH11509179A (ja) ロイコトリエン拮抗薬としてのヘテロアリールジオール酸
AU705938B2 (en) Pyridazino quinoline compounds
NZ539954A (en) New tricyclic derivatives as LTD4 antagonists
JP2001518469A (ja) 三環式３−オキソ−プロパンニトリル化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060929

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060929

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100423

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101012